These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32914346)

  • 1. Effect of the dipeptidyl peptidase-4 inhibitor linagliptin on atherosclerotic lesions in Watanabe heritable hyperlipidemic rabbits: iMap-IVUS and pathological analysis.
    Kurosawa T; Li Y; Sudo M; Haruta H; Hagikura K; Takayama T; Hiro T; Shiomi M; Hao H; Matsumoto T; Hirayama A; Okumura Y
    Heart Vessels; 2021 Jan; 36(1):127-135. PubMed ID: 32914346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of plaque progression and promotion of plaque stability by glucagon-like peptide-1 receptor agonist: Serial in vivo findings from iMap-IVUS in Watanabe heritable hyperlipidemic rabbits.
    Sudo M; Li Y; Hiro T; Takayama T; Mitsumata M; Shiomi M; Sugitani M; Matsumoto T; Hao H; Hirayama A
    Atherosclerosis; 2017 Oct; 265():283-291. PubMed ID: 28693828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dipeptidyl peptidase 4 inhibition on inflammation in atherosclerosis: A
    Virta J; Hellberg S; Liljenbäck H; Ståhle M; Silvola JMU; Huusko J; Söderström M; Knuuti J; Nuutila P; Ylä-Herttuala S; Gomez MF; Roivainen A; Saraste A
    Atherosclerosis; 2020 Jul; 305():64-72. PubMed ID: 32386751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of atherosclerotic plaque volume in hyperlipidemic rabbit aorta by intravascular ultrasound.
    Iwata A; Miura S; Imaizumi S; Zhang B; Saku K
    J Cardiol; 2007 Oct; 50(4):229-34. PubMed ID: 17987838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilization of atherosclerotic plaque by pitavastatin in Watanabe heritable hyperlipidemic rabbits: A serial tissue-characterizing intravascular ultrasound study.
    Haruta H; Hiro T; Mitsumata M; Takayama T; Sudo M; Li Y; Takahashi R; Taniguchi Y; Shiomi M; Hirayama A
    J Cardiol; 2016 Feb; 67(2):205-11. PubMed ID: 26194868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anagliptin, a dipeptidyl peptidase-4 inhibitor, decreases macrophage infiltration and suppresses atherosclerosis in aortic and coronary arteries in cholesterol-fed rabbits.
    Hirano T; Yamashita S; Takahashi M; Hashimoto H; Mori Y; Goto M
    Metabolism; 2016 Jun; 65(6):893-903. PubMed ID: 27173468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, attenuates cardiac dysfunction after myocardial infarction independently of DPP-4.
    Yamaguchi T; Watanabe A; Tanaka M; Shiota M; Osada-Oka M; Sano S; Yoshiyama M; Miura K; Kitajima S; Matsunaga S; Tomita S; Iwao H; Izumi Y
    J Pharmacol Sci; 2019 Feb; 139(2):112-119. PubMed ID: 30638989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sitagliptin on coronary atherosclerosis evaluated using integrated backscatter intravascular ultrasound in patients with type 2 diabetes: rationale and design of the TRUST study.
    Nozue T; Fukui K; Koyama Y; Fujii H; Kunishima T; Hikita H; Hibi K; Miyazawa A; Michishita I
    Heart Vessels; 2016 May; 31(5):649-54. PubMed ID: 25794984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of inflammation-mediated DPP-4 expression by linagliptin increases M2 macrophages in atherosclerotic lesions.
    Nishida S; Matsumura T; Senokuchi T; Murakami-Nishida S; Ishii N; Morita Y; Yagi Y; Motoshima H; Kondo T; Araki E
    Biochem Biophys Res Commun; 2020 Mar; 524(1):8-15. PubMed ID: 31964532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiatherogenic effects of newly developed apolipoprotein A-I mimetic peptide/phospholipid complexes against aortic plaque burden in Watanabe-heritable hyperlipidemic rabbits.
    Iwata A; Miura S; Zhang B; Imaizumi S; Uehara Y; Shiomi M; Saku K
    Atherosclerosis; 2011 Oct; 218(2):300-7. PubMed ID: 21696737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dipeptidyl peptidase-4 inhibitor, linagliptin, ameliorates endothelial dysfunction and atherogenesis in normoglycemic apolipoprotein-E deficient mice.
    Salim HM; Fukuda D; Higashikuni Y; Tanaka K; Hirata Y; Yagi S; Soeki T; Shimabukuro M; Sata M
    Vascul Pharmacol; 2016 Apr; 79():16-23. PubMed ID: 26277250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary dipeptidyl peptidase-4 protein is increased by linagliptin and is a potential predictive marker of urine albumin-to-creatinine ratio reduction in patients with type 2 diabetes.
    Klein T; Tammen H; Mark M; Benetti E; Delić D; Schepers C; von Eynatten M
    Diabetes Obes Metab; 2021 Aug; 23(8):1968-1972. PubMed ID: 33881796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visualization of coronary plaque in type 2 diabetes mellitus patients using a new 40 MHz intravascular ultrasound imaging system.
    Araki T; Nakamura M; Utsunomiya M; Sugi K
    J Cardiol; 2012 Jan; 59(1):42-9. PubMed ID: 21890326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of vascular dipeptidyl peptidase-4 inhibition on vascular protection in Zucker diabetic fatty rats.
    Takai S; Sakonjo H; Jin D
    J Pharmacol Sci; 2014; 125(4):386-93. PubMed ID: 25030743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Ameliorates High-fat Induced Cognitive Decline in Tauopathy Model Mice.
    Nakaoku Y; Saito S; Yamamoto Y; Maki T; Takahashi R; Ihara M
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31126115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DPP-4 Inhibition by Linagliptin Attenuates Obesity-Related Inflammation and Insulin Resistance by Regulating M1/M2 Macrophage Polarization.
    Zhuge F; Ni Y; Nagashimada M; Nagata N; Xu L; Mukaida N; Kaneko S; Ota T
    Diabetes; 2016 Oct; 65(10):2966-79. PubMed ID: 27445264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue characterization and phenotype classification in patients presenting with acute myocardial infarction: Insights from the iWonder study.
    Souza CF; Maehara A; Mintz GS; Matsumura M; Alves CMR; Carlos Carvalho A; Caixeta A
    Catheter Cardiovasc Interv; 2017 Dec; 90(7):1107-1114. PubMed ID: 28191713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherosclerotic plaque identification by virtual histology intravascular ultrasound in a rabbit abdominal aorta model of vulnerable plaque.
    Lin QF; Luo YK; Zhao ZW; Cai W; Zhen XC; Chen LL
    Exp Biol Med (Maywood); 2013 Nov; 238(11):1223-32. PubMed ID: 24085783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intravascular ultrasound with virtual histology in assessment of atherosclerotic plaque composition in patients with coronary artery disease and type 2 diabetes mellitus].
    Zakharov AS; Michurova MS; Terekhin SA; Kalashnikov VY; Smirnova OM; Shestakova MV; Dedov II
    Ter Arkh; 2019 Dec; 91(12):41-46. PubMed ID: 32598588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure and glucose independent renoprotective effects of dipeptidyl peptidase-4 inhibition in a mouse model of type-2 diabetic nephropathy.
    Sharkovska Y; Reichetzeder C; Alter M; Tsuprykov O; Bachmann S; Secher T; Klein T; Hocher B
    J Hypertens; 2014 Nov; 32(11):2211-23; discussion 2223. PubMed ID: 25215436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.